First Time Loading...

Inogen Inc
NASDAQ:INGN

Watchlist Manager
Inogen Inc Logo
Inogen Inc
NASDAQ:INGN
Watchlist
Price: 6.71 USD 0.15%
Updated: Apr 25, 2024

Intrinsic Value

INGN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirator... [ Read More ]

The intrinsic value of one INGN stock under the Base Case scenario is 20.47 USD. Compared to the current market price of 6.71 USD, Inogen Inc is Undervalued by 67%.

Key Points:
INGN Intrinsic Value
Base Case
20.47 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Inogen Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling INGN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Inogen Inc

Provide an overview of the primary business activities
of Inogen Inc.

What unique competitive advantages
does Inogen Inc hold over its rivals?

What risks and challenges
does Inogen Inc face in the near future?

Has there been any significant insider trading activity
in Inogen Inc recently?

Summarize the latest earnings call
of Inogen Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inogen Inc.

Provide P/S
for Inogen Inc.

Provide P/E
for Inogen Inc.

Provide P/OCF
for Inogen Inc.

Provide P/FCFE
for Inogen Inc.

Provide P/B
for Inogen Inc.

Provide EV/S
for Inogen Inc.

Provide EV/GP
for Inogen Inc.

Provide EV/EBITDA
for Inogen Inc.

Provide EV/EBIT
for Inogen Inc.

Provide EV/OCF
for Inogen Inc.

Provide EV/FCFF
for Inogen Inc.

Provide EV/IC
for Inogen Inc.

Show me price targets
for Inogen Inc made by professional analysts.

What are the Revenue projections
for Inogen Inc?

How accurate were the past Revenue estimates
for Inogen Inc?

What are the Net Income projections
for Inogen Inc?

How accurate were the past Net Income estimates
for Inogen Inc?

What are the EPS projections
for Inogen Inc?

How accurate were the past EPS estimates
for Inogen Inc?

What are the EBIT projections
for Inogen Inc?

How accurate were the past EBIT estimates
for Inogen Inc?

Compare the revenue forecasts
for Inogen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inogen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inogen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inogen Inc compared to its peers.

Compare the P/E ratios
of Inogen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Inogen Inc with its peers.

Analyze the financial leverage
of Inogen Inc compared to its main competitors.

Show all profitability ratios
for Inogen Inc.

Provide ROE
for Inogen Inc.

Provide ROA
for Inogen Inc.

Provide ROIC
for Inogen Inc.

Provide ROCE
for Inogen Inc.

Provide Gross Margin
for Inogen Inc.

Provide Operating Margin
for Inogen Inc.

Provide Net Margin
for Inogen Inc.

Provide FCF Margin
for Inogen Inc.

Show all solvency ratios
for Inogen Inc.

Provide D/E Ratio
for Inogen Inc.

Provide D/A Ratio
for Inogen Inc.

Provide Interest Coverage Ratio
for Inogen Inc.

Provide Altman Z-Score Ratio
for Inogen Inc.

Provide Quick Ratio
for Inogen Inc.

Provide Current Ratio
for Inogen Inc.

Provide Cash Ratio
for Inogen Inc.

What is the historical Revenue growth
over the last 5 years for Inogen Inc?

What is the historical Net Income growth
over the last 5 years for Inogen Inc?

What is the current Free Cash Flow
of Inogen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inogen Inc.

Financials

Balance Sheet Decomposition
Inogen Inc

Current Assets 207.1m
Cash & Short-Term Investments 128.5m
Receivables 42.9m
Other Current Assets 35.7m
Non-Current Assets 119.1m
PP&E 70.7m
Intangibles 44.6m
Other Non-Current Assets 3.8m
Current Liabilities 72.5m
Accounts Payable 23.5m
Accrued Liabilities 21.4m
Other Current Liabilities 27.6m
Non-Current Liabilities 48.9m
Other Non-Current Liabilities 48.9m
Efficiency

Earnings Waterfall
Inogen Inc

Revenue
315.7m USD
Cost of Revenue
-189m USD
Gross Profit
126.7m USD
Operating Expenses
-203.2m USD
Operating Income
-76.5m USD
Other Expenses
-26m USD
Net Income
-102.4m USD

Free Cash Flow Analysis
Inogen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

INGN Profitability Score
Profitability Due Diligence

Inogen Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
22/100
Profitability
Score

Inogen Inc's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

INGN Solvency Score
Solvency Due Diligence

Inogen Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Inogen Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INGN Price Targets Summary
Inogen Inc

Wall Street analysts forecast INGN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INGN is 6.63 USD with a low forecast of 6.06 USD and a high forecast of 7.35 USD.

Lowest
Price Target
6.06 USD
10% Downside
Average
Price Target
6.63 USD
1% Downside
Highest
Price Target
7.35 USD
10% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

INGN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

INGN Price
Inogen Inc

1M 1M
-11%
6M 6M
+48%
1Y 1Y
-49%
3Y 3Y
-89%
5Y 5Y
-92%
10Y 10Y
-54%
Annual Price Range
6.71
52w Low
4.21
52w High
13.86
Price Metrics
Average Annual Return -29.39%
Standard Deviation of Annual Returns 10.95%
Max Drawdown -96%
Shares Statistics
Market Capitalization 156.3m USD
Shares Outstanding 23 330 000
Percentage of Shares Shorted 10.2%

INGN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Inogen Inc Logo
Inogen Inc

Country

United States of America

Industry

Health Care

Market Cap

156.3m USD

Dividend Yield

0%

Description

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,021 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen with a single battery and can be plugged into a power outlet as needed. All of its Inogen One systems are equipped with Intelligent Delivery Technology, a form of pulse-dose technology, from which the patient receives a bolus of oxygen upon inhalation. The company has also launched Inogen Connect, a wireless connectivity platform for the Inogen One G4 and Inogen One G5 (portable oxygen concentrators) consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

Contact

CALIFORNIA
Goleta
326 Bollay Dr
+18055620500.0
https://www.inogen.com/

IPO

2014-02-14

Employees

1 021

Officers

Executive VP, General Counsel & Corporate Secretary
Mr. Jason Somer
Executive VP of R&D and Chief Medical Officer
Dr. Stanislav Glezer M.D., MBA
President, CEO & Director
Mr. Kevin R. M. Smith
Executive VP, CFO & Treasurer
Mr. Michael J. Bourque
Senior Vice President of Operations & Supply Chain
Mr. Philip Corrin
Executive VP & Chief Human Resources Officer
Ms. Jennifer Yi Boyer
Show More
Senior Vice President of Enterprise Enablement
Mr. Vijay Paliwal
Executive VP & Chief Commercial Officer
Mr. Grgoire Ramade
Show Less

See Also

Discover More
What is the Intrinsic Value of one INGN stock?

The intrinsic value of one INGN stock under the Base Case scenario is 20.47 USD.

Is INGN stock undervalued or overvalued?

Compared to the current market price of 6.71 USD, Inogen Inc is Undervalued by 67%.